NCT01683318

Treatment of Meibomian Gland Dysfunction

Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Singapore National Eye Centre · Other Government
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The current study aims to test the efficacy of treatment for a device that utilises a thermal pulsation system, which applies heat from the inner surface of the eyelids (Lipiflow) in patients suffering from meibomian gland dysfunction. Patients will be asked to undergo a one-time treatment with Lipiflow and the investigators will monitor them for changes in tear film and lipid composition, as well as changes in the anatomy of meibomian glands for over a study period of 12 weeks. Additionally, dry eye symptoms will be documented in form of questionnaires. The investigators hypothesize that the treatment will be effective in improving clinical signs and will relieve dry eye symptoms for the patient. If this method of managing Meibomian Gland Dysfunction (MGD) is found to be efficacious and safe, it will be made available to patients in Singapore.

Conditions

• Meibomian Gland Dysfunction (MGD)

Interventions

Type	Name	Description
PROCEDURE	Thermal Pulsation therapy

Timeline

• Start date: 2012-09-01
• Primary completion: 2013-10-01
• First posted: 2012-09-11
• Last updated: 2013-11-13

Locations

1 site across 1 country: Singapore